Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy

Detalles Bibliográficos
Autores principales: Miri, Seyed Mohammad, Tafsiri, Elham, Cho, William Chi Shing, Ghaemi, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594476/
https://www.ncbi.nlm.nih.gov/pubmed/33132758
http://dx.doi.org/10.1186/s12935-020-01609-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594476/
https://www.ncbi.nlm.nih.gov/pubmed/33132758
http://dx.doi.org/10.1186/s12935-020-01609-w

Ejemplares similares